Ocugen, Inc. (OCGN)
1.905
-0.04
(-2.31%)
USD |
NASDAQ |
Apr 16, 13:13
Ocugen Research and Development Expense (Quarterly) : 10.67M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| REGENXBIO, Inc. | 55.74M |
| Krystal Biotech, Inc. | 13.23M |
| Phathom Pharmaceuticals, Inc. | 7.493M |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| MannKind Corp. | 27.59M |